Newsfeeds - Spark Newswire

4 minute read

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar

By Shanthi Rexaline

Today, 7:17 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ALKS

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 7:17 PM

During Friday's session, 445 companies made new 52-week lows.

AAOI

4 minute read

Stocks Hitting New 52-Week Lows Today

By Benzinga Insights

Today, 7:17 PM

On Monday morning, 60 companies achieved new lows for the year.

AGIL

3 minute read

22 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 7:17 PM

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday.

AEI

12 minute read

Earnings Scheduled For November 8, 2021

By Benzinga Insights

Today, 7:17 PM

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.

ACAD

2 minute read

Editas Medicine Says Clinical Data From Ongoing Phase 1/2 BRILLIANCE Clinical Trial Of EDIT-101 For LCA10 To Be Presented At European Society Of Gene And Cell Therapy Annual Congress

By Benzinga Newsdesk

Today, 7:17 PM

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that an abstract featuring initial clinical data from the BRILLIANCE clinical trial of EDIT-101 has been selected for an oral

EDIT

1 minute read

Analyst Ratings

Analyst Ratings For Editas Medicine

By Benzinga Insights

Today, 7:17 PM

Within the last quarter, Editas Medicine (NASDAQ:EDIT) has observed the following analyst ratings:

EDIT

1 minute read

Cathie Wood’s ARK Invest Posts Fund Sales For Monday, Oct. 11, 2021: SHOP, SE, NSTG, PRLB, IRDM, COIN, NXPI, LC, SMFR, TAK, VEEV, SDGR, EDIT, VRTX, REGN, OPEN

By Benzinga Newsdesk

Today, 7:17 PM

Shopify (SHOP) - 860 Sea (SE) - 5,757 NanoString Technologies (NSTG) - 160,139 Proto Labs (PRLB) - 152,226 Iridium Communications (IRDM)

COIN

2 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 7:17 PM

AGRX

1 minute read

Editas Medicine To Present Preclinical Data On Novel Engineered iPSC Derived NK Cells For Treatment Of Cancer At Society For Immunotherapy Of Cancer 36th Annual Meeting

By Benzinga Newsdesk

Today, 7:17 PM

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that the Company will present preclinical data on its progress in the development of cell therapy medicines for the treatment of

EDIT